Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer

Documenti analoghi

• SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis
  di: Chen Tang, et al.
  Pubblicazione: (2025)
• Clinical homologous recombination repair gene reversion analysis identifies mechanisms of resistance to PARP inhibitors and platinum‐chemotherapy
  di: Yan Jia, et al.
  Pubblicazione: (2024)
• Inhibition of 15‐hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic stroke
  di: Yunfei Xu, et al.
  Pubblicazione: (2024)
• Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4
  di: Jiangchun Wu, et al.
  Pubblicazione: (2024)
• Ubiquitin‐specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling
  di: Huiyan Sun, et al.
  Pubblicazione: (2024)